Department of Tumor Genetics and Immunogenetics, Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany.
Department of Hematology, Oncology and Tumorimmunology, Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany.
Cancer Discov. 2014 Dec;4(12):1448-65. doi: 10.1158/2159-8290.CD-14-0096. Epub 2014 Sep 24.
In human chronic lymphocytic leukemia (CLL) pathogenesis, B-cell antigen receptor signaling seems important for leukemia B-cell ontogeny, whereas the microenvironment influences B-cell activation, tumor cell lodging, and provision of antigenic stimuli. Using the murine Eμ-Tcl1 CLL model, we demonstrate that CXCR5-controlled access to follicular dendritic cells confers proliferative stimuli to leukemia B cells. Intravital imaging revealed a marginal zone B cell-like leukemia cell trafficking route. Murine and human CLL cells reciprocally stimulated resident mesenchymal stromal cells through lymphotoxin-β-receptor activation, resulting in CXCL13 secretion and stromal compartment remodeling. Inhibition of lymphotoxin/lymphotoxin-β-receptor signaling or of CXCR5 signaling retards leukemia progression. Thus, CXCR5 activity links tumor cell homing, shaping a survival niche, and access to localized proliferation stimuli.
CLL and other indolent lymphoma are not curable and usually relapse after treatment, a process in which the tumor microenvironment plays a pivotal role. We dissect the consecutive steps of CXCR5-dependent tumor cell lodging and LTβR-dependent stroma-leukemia cell interaction; moreover, we provide therapeutic solutions to interfere with this reciprocal tumor-stroma cross-talk.
在人类慢性淋巴细胞白血病(CLL)发病机制中,B 细胞抗原受体信号似乎对白血病 B 细胞发生很重要,而微环境影响 B 细胞激活、肿瘤细胞黏附以及提供抗原刺激。我们使用 Eμ-Tcl1 小鼠 CLL 模型证明,CXCR5 控制对滤泡树突状细胞的访问为白血病 B 细胞提供了增殖刺激。活体成像显示了边缘区 B 细胞样白血病细胞的迁移途径。小鼠和人类 CLL 细胞通过淋巴毒素-β-受体激活相互刺激常驻间充质基质细胞,导致 CXCL13 分泌和基质区室重塑。抑制淋巴毒素/淋巴毒素-β-受体信号或 CXCR5 信号会延迟白血病进展。因此,CXCR5 活性将肿瘤细胞归巢、形成生存生态位以及获得局部增殖刺激联系起来。
CLL 和其他惰性淋巴瘤无法治愈,通常在治疗后复发,在此过程中肿瘤微环境起着关键作用。我们剖析了 CXCR5 依赖性肿瘤细胞黏附和 LTβR 依赖性基质-白血病细胞相互作用的连续步骤;此外,我们提供了治疗解决方案来干扰这种互惠的肿瘤-基质交叉对话。